IL17A and neurodevelopmental disorder: Sreenivas et al. reported that in studies on neurodevelopmental disorders, the Compensatory Immune Regulatory System (CIRS) is activated, with increased IL-1 signaling, decreased levels of IL-1 receptor antagonists, and augmented levels of CCL2 and IL-17.22